Anneli Thuresson

Statistics

Publications

Citations

284

H-Index

Active since

1997

Affiliations

AstraZeneca (Sweden)(Current)

Anneli Thuresson is an author at AstraZeneca (Sweden) specializing in anticoagulant pharmacology, anticoagulation therapy, and direct thrombin inhibitors.

Publications per year

1997–2003

Publications

Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans

Ulf G. Eriksson, Ulf Bredberg, Kurt‐Jürgen Hoffmann et al. · Drug Metabolism and Disposition · 2003 · 155 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Pharmacokinetics, pharmacodynamics and clinical effects of the oral direct thrombin inhibitor ximelagatran in acute treatment of patients with pulmonary embolism and deep vein thrombosis

Karin Wåhlander, Leif Lapidus, Carl‐Gustav Olsson et al. · Thrombosis Research · 2002 · 69 citations

Medicine, Pharmacokinetics, Pharmacology +16

Developmentally Regulated Expression of the CYP4AGenes in the Spontaneously Hypertensive Rat Kidney

Deanna L. Kroetz, Linn M. Huse, Anneli Thuresson et al. · Molecular Pharmacology · 1997 · 60 citations

Life Sciences, Biochemistry, Molecular Biology +10

1–3 of 3